Because of an editing error, an article and a picture caption on Tuesday about the Army's proposal to dispose of the nerve agent VX misidentified the substance that the DuPont Company would treat in southern New Jersey under an Army contract. It is hydrolysate, a nonlethal byproduct that will result when VX is neutralized at a depot in Indiana -- not the nerve agent itself.
